脂蛋白相关磷脂酶A2与脑梗死患者颈部动脉粥样硬化斑块的关系

doi:10.3969/j.issn.1673-5765.2019.02.007

摘要/Abstract

摘要：

目的探讨脑梗死患者血清脂蛋白相关磷脂酶A2（lipoprotein-related phospholipase A2，Lp-PLA2）及超敏C反应蛋白（hi gh-sensitivity C-reactive protein，hs-CRP）水平与颈部动脉粥样硬化性斑块的关系。方法选择2017年1月-2018年3月郑州市第三人民医院诊断为脑梗死的患者243例，另外选择同期体检的无脑梗死患者120例作为对照组。2组研究对象均检测血清Lp-PLA2、hs-CRP水平。依据颈部动脉超声检查结果将脑梗死患者进一步分为无斑块组、稳定斑块组和易损斑块组。结果 ①脑梗死患者的血清Lp-PLA2（[ 180.04±35.02）ng/mL vs（152.13±39.67）ng/mL，P=0.014]、 hs-CRP[（10.02±0.47）mg/L vs（2.64±0.33）mg/L，P =0.017]水平高于对照组。②稳定斑块组（[ 162.96±11.34）ng/mL，P=0.013]和易损斑块组（[ 197.79±32.56）ng/mL，P=0.004]Lp-PLA2水平高于无斑块组（[ 143.67±12.35）ng/mL]；易损斑块组Lp-PLA2水平高于稳定斑块组（P=0.007），差异均有统计学意义。③易损斑块组血清hs-CRP水平[（12.86±1.67）mg/L]高于稳定斑块组[（10.82±0.53） mg/L，P=0.029]及无斑块组（[ 9.54±0.47）mg/L，P=0.037]，差异有统计学意义。结论在脑梗死患者中，血清Lp-PLA2与hs-CRP可能与颈部动脉粥样硬化斑块的发生及其不稳定性有关。

文章导读： 本研究通过病例对照分析显示脑梗死患者血清Lp-PLA2及hs-CRP水平高于无脑梗死组，且Lp-PLA2和hs-CRP水平与脑梗死患者颈部动脉粥样硬化斑块的发生和进展有关。

Abstract:

Objective To investigate the relationship between serum lipoprotein-related phospholipase A2 (Lp- PLA2) and high-sensitivity C-reactive protein (hs-CRP) levels and carotid atherosclerotic plaque in patients with cerebral infarction. Methods 243 patients diagnosed with cerebral infarction in the Third People’s Hospital of Zhengzhou from January 2017 to March 2018 were selected as cerebral infarction group, and 120 subjects without cerebral infarction through physical examination in this hospital during the same period were selected as control group. Serum Lp-PLA2 and hs-CRP levels were detected in the two groups. According to the results of carotid artery ultrasound examination, the patients with cerebral infarction were divided into non-plaque group, stable plaque group and vulnerable plaque group. Results (1) Serum Lp-PLA2 level [(180.04±35.02) ng/mL vs (152.13±39.67) ng/mL, P =0.014] and hs-CRP level [(10.02±0.47) mg/L vs (2.64±0.33) mg/L, P =0.017] in cerebral infarction group were higher than those in control group. (2) Serum Lp-PLA2 level in the stable plaque group [(162.96±11.34) ng/mL vs (143.67±12.35) ng/mL, P =0.013] and vulnerable plaque group [(197.79±32.56) ng/mL vs (143.67±12.35) ng/mL, P =0.004] were both significantly higher than that in the non-plaque group. Serum Lp-PLA2 level in vulnerable plaque group (P =0.007) was higher than that in stable plaque group. (3) Serum hs-CRP level in vulnerable plaque group were higher than that in stable plaque group [(12.86±1.67) mg/L vs (10.82±0.53) mg/L, P =0.029] and nonplaque group [(12.86±1.67)mg/L vs (9.54±0.47) mg/L, P =0.037] . Conclusions The serum Lp-PLA2 and hs-CRP level probably predicted the development and instability of carotid artery plaques in patients with cerebral infarction.

Key words: Lipoprotein associated phospholipase A2; Hypersensitive C-reactive protein;Cerebral infarction; Atherosclerotic

嵇朋，屈雪萍，周衡. 脂蛋白相关磷脂酶A2与脑梗死患者颈部动脉粥样硬化斑块的关系[J]. 中国卒中杂志, 2019, 14(02): 121-125.

JI Peng, QU Xue-Ping, ZHOU Heng. The Relationship between Serum Lipoprotein-Associated Phospholipase A2 and hs-CRP Level and Carotid Artery Plaque in Patients with Cerebral Infarction[J]. Chinese Journal of Stroke, 2019, 14(02): 121-125.

参考文献

[1] LI Y. Analysis of intima-media thickness of carotid

artery and lipoprotein-associated phospholipase A2

in coronary heart diseases of different types[J/OL].

Technol Health Care，2015，23（s1）：S147-S150.

https：//doi.org/10.3233/thc-150947.

[2] IKONOMIDIS I，KADOGLOU N N P，TRITAKIS

V，et al. Association of Lp-PLA2 with digital

reactive hyperemia，coronary flow reserve，carotid

atherosclerosis and arterial stiffness in coronary

artery disease[J]. Atherosclerosis，2014，234（1）：

34-41.

[3] RIBA-LLENA I，PENALBA A，PELEGRÍ D，et

al. Role of lipoprotein-associated phospholipase A2

activity for the prediction of silent brain infarcts in

women[J]. Atherosclerosis，2014，237（2）：811-815.

[4] 中华医学会神经病学分会脑血管病学组中华医学

会神经病学分会. 中国急性缺血性脑卒中诊治指南

2014[J]. 中华神经科杂志，2015，48（4）：246-257.

[5] SAIRAM S G，SOLA S，BAROOAH A，et al. The

role of Lp-PLA2 and biochemistry parameters as

potential biomarkers of coronary artery disease

in Asian South-Indians：a case-control study[J].

Cardiovasc Diagn Ther，2017，7（6）：589-597.

[6] WHELTON P K，CAREY R M，ARONOW W

S，et al. 2017 ACC/AHA/AAPA/ABC/ACPM/

AGS/APhA/ASH/ASPC/NMA/PCNA Guideline

for the Prevention，Detection，Evaluation，and

Management of High Blood Pressure in Adults：A

Report of the American College of Cardiology/

American Heart Association Task Force on Clinical

Practice Guidelines[J/OL]. Circulation，2018，

138（17）：e484-e594. https：//doi.org/10.1161/

CIR.0000000000000596.

[7] 中华医学会糖尿病学分会. 中国2型糖尿病防治指

南（2017年版）[J]. 中国实用内科杂志，2018，38（4）：

292-344.

[8] 华扬，惠品晶，邢英琦. 中国脑卒中血管超声检查指

导规范[J]. 中华医学超声杂志（电子版），2015，12

（8）：599-610.

[9] 苏博，勇强，李治安. 超声技术检测脑梗死患者颈动

脉不稳定斑块[J]. 诊断学理论与实践，2008，7（2）：

211-212.

[10] YANG Y，XUE T，ZHU J，et al. Serum lipoproteinassociated

phospholipase A2 predicts the formation

of carotid artery plaque and its vulnerability in

anterior circulation cerebral infarction[J/OL]. Clin

Neurol Neurosurg，2017，160：40-45. https：//doi.

org/10.1016/j.clineuro.2017.06.007.

[11] OTSUKA F，ZHAO X，TROUT H H，et al.

Community-based statins and advanced carotid

plaque：Role of CD163 positive macrophages in

lipoprotein-associated phospholipase A2 activity

in atherosclerotic plaque[J/OL]. Atherosclerosis，

2017，267：78-89. https：//doi.org/10.1016/

j.atherosclerosis.2017.10.014.

[12] WHITE H D，SIMES J，STEWART R A H，et al.

Changes in Lipoprotein-Associated Phospholipase

A2 Activity Predict Coronary Events and Partly

Account for the Treatment Effect of Pravastatin：

Results From the Long-term Intervention with

Pravastatin in Ischemic Disease Study[J/OL]. J Am

Heart Assoc，2013，2（5）：e000360. https：//doi.

org/10.1161/JAHA.113.000360.

[13] YANG X，ZHANG H，SHI Y，et al. Association

of serum angiopoietin-2 with malnutrition，

inflammation，atherosclerosis and valvular

calcification syndrome and outcome in peritoneal

dialysis patients：a prospective cohort study[J]. J

Transl Med，2018，16（1）：312.

[14] WEI L，KE Z，ZHAO Y，et al. The elevated

lipoprotein-associated phospholipase A2 activity is

associated with the occurrence and recurrence of

acute cerebral infarction[J]. Neuroreport，2017，28

（6）：325-330.

[15] MAYER O，SEIDLEROVÁ J，FILIPOVSKÝ J，et al.

Unexpected inverse relationship between impaired

glucose metabolism and lipoprotein-associated

phospholipase A2 activity in patients with stable

vascular disease[J]. Eur J Intern Med，2014，25（6）：

556-560.

[16] LIU J，WANG W，QI Y，et al. Association between

the lipoprotein-associated phospholipase A2 activity

and the progression of subclinical atherosclerosis[J].

J Atheroscler Thromb，2014，21（6）：532-542.

[17] XIONG L，SUN W，CAI H，et al. Correlation

of enhancement degree on contrast-enhanced

ultrasound with histopathology of carotid plaques

and serum high sensitive C-reactive protein levels

in patients undergoing carotid endarterectomy[J]. J

Huazhong Univ Sci Technolog Med Sci，2017，37（3）：

425-428.

[18] SARLON-BARTOLI G，BOUDES A，BUFFAT

C，et al. Circulating lipoprotein-associated

phospholipase a2 in high-grade carotid stenosis：a

new biomarker for predicting unstable plaque[J]. Eur

J Vasc Endovasc Surg，2012，43（2）：154-159.